Published in J Exp Med on June 01, 1971
Studies of genetic transmission of murine leukemia virus by AKR mice. I. Crosses with Fv-1 n strains of mice. J Exp Med (1972) 6.52
Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice. Proc Natl Acad Sci U S A (1976) 4.52
The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med (1974) 3.53
Endogenous oncornaviral gene expression in adult and fetal mice: quantitative, histologic, and physiologic studies of the major viral glycorprotein, gp70. J Exp Med (1976) 3.51
Definitive evidence that the murine C-type virus inducing locus Akv-1 is viral genetic material. Proc Natl Acad Sci U S A (1975) 3.51
Biochemical evidence linking the GIX thymocyte surface antigen to the gp69/71 envelope glycoprotein of murine leukemia virus. J Exp Med (1975) 3.31
Identification of ecotropic proviral sequences in inbred mouse strains with a cloned subgenomic DNA fragment. Proc Natl Acad Sci U S A (1980) 3.19
Relation of GIX antigen of thymocytes to envelope glycoprotein of murine leukemia virus. J Exp Med (1975) 3.06
A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J Virol (1990) 3.00
Identification of a p69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells. J Exp Med (1980) 2.89
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. II. Mammalian leukemia-sarcoma viruses. J Virol (1972) 2.84
Host-gene control of C-type RNA tumor virus: inheritance of the group-specific antigen of murine leukemia virus. Proc Natl Acad Sci U S A (1971) 2.65
The oncornavirus glycoprotein gp69/71: a constituent of the surface of normal and malignant thymocytes. J Exp Med (1975) 2.37
Host control of endogenous murine leukemia virus gene expression: concentrations of viral proteins in high and low leukemia mouse strains. Proc Natl Acad Sci U S A (1974) 2.28
Identification and cloning of endogenous retroviral sequences present in human DNA. Proc Natl Acad Sci U S A (1981) 2.26
Evidence for recombination between N- and B-tropic murine leukemia viruses. J Virol (1977) 2.20
Age-related changes in cell surface antigens of preleukemic AKR thymocytes. J Exp Med (1976) 2.15
Induction of GIX antigen and gross cell surface antigen after infection by ecotropic and xenotropic murine leukemia viruses in vitro. J Virol (1976) 2.11
G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody. J Exp Med (1979) 1.63
Expression of murine leukemia virus envelope glycoprotein gp69/71 on mouse thymocytes. Evidence for two structural variants distinguished by presence vs. absence of GIX antigen. J Exp Med (1975) 1.62
Viral and cellular surface antigens of murine leukemias and myelomas. Serological analysis by immunoelectron microscopy. J Exp Med (1972) 1.62
Viral proteins expressed on the surface of murine leukemia cells. J Virol (1977) 1.60
New mutant and congenic mouse stocks expressing the murine leukemia virus-associated thymocyte surface antigen GIX. J Exp Med (1975) 1.59
Family of middle repetitive DNA sequences in the mouse genome with structural features of solitary retroviral long terminal repeats. Proc Natl Acad Sci U S A (1983) 1.54
Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection. J Exp Med (1985) 1.52
Relationship of GIX antigen expression to the glycosylation of murine leukemia virus glycoprotein. Proc Natl Acad Sci U S A (1980) 1.48
Detection and cloning of murine leukemia virus-related sequences from African green monkey liver DNA. J Virol (1981) 1.38
Nucleotide sequence of the env-specific segment of NFS-Th-1 xenotropic murine leukemia virus. J Virol (1983) 1.34
Antibody directed to determinants of a Moloney virus derived MCF GP70 recognizes a thymic differentiation antigen. J Exp Med (1983) 1.32
Abelson antigen: a viral tumor antigen that is also a differentiation antigen of BALB/c mice. Proc Natl Acad Sci U S A (1978) 1.32
Wild-type gross leukemia virus: classification of soluble antigens (GSA). J Virol (1972) 1.31
Effector cells in allelic H-2 class I-incompatible skin graft rejection. J Exp Med (1987) 1.31
Murine serum glycoprotein gp70 behaves as an acute phase reactant. J Exp Med (1982) 1.29
Relation of chromosome 4 (linkage group 8) to murine leukemia virus-associated antigens of AKR mice. J Exp Med (1973) 1.27
Common cell-surface antigen associated with murine and feline C-type RNA leukemia viruses. Proc Natl Acad Sci U S A (1973) 1.20
A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes. J Exp Med (1979) 1.20
T1 oligonucleotides that segregate with tropism and with properties of gp70 in recombinants between N- and B-tropic murine leukemia viruses. J Virol (1978) 1.19
Relationship of infectious murine leukemia virus and virus-related antigens in genetic crosses between AKR and the Fv-1 compatible strain C57L. J Exp Med (1976) 1.18
Low-calorie diet selectively reduces expression of retroviral envelope glycoprotein gp70 in sera of NZB x NZW F1 hybrid mice. J Exp Med (1981) 1.17
Spontaneous autoimmunization to GIX cell surface antigen in hybrid mice. J Exp Med (1976) 1.16
Abelson antigen is expressed on hematopoietic spleen colony-forming cells from mice carrying the Av-2S virus sensitivity gene. Proc Natl Acad Sci U S A (1979) 1.15
G(RADA1): a new cell surface antigen of mouse leukemia defined by naturally occurring antibody and its relationship to murine leukemia virus. J Exp Med (1978) 1.15
Molecular cloning and characterization of gag-, pol-, and env-related gene sequences in the ev- chicken. J Virol (1986) 1.13
Induction of high serum levels of retroviral env gene products (gp70) in mice by bacterial lipopolysaccharide. Proc Natl Acad Sci U S A (1981) 1.13
Heredity of the GIX thymocyte antigen associated with murine leukemia virus: segregation data simulating genetic linkage. Proc Natl Acad Sci U S A (1976) 1.13
X-gp70: a third molecular species of the envelope protein gp70 of murine leukemia virus, expressed on mouse lymphoid cells. J Exp Med (1976) 1.12
Preleukemic expression of TL antigens in x-irradiated C57BL/6 mice. J Exp Med (1977) 1.10
A genetic locus regulates the expression of tissue-specific mRNAs from multiple transcription units. Proc Natl Acad Sci U S A (1982) 1.10
Expression of AKR murine leukemia virus gp71-like and BALB(X) gp-71-like antigens in normal mouse tissues in the absence of overt virus expression. J Exp Med (1977) 1.08
Two species of type C viral core polyprotein on AKR mouse leukemia cells. J Virol (1977) 1.08
Murine leukemia virus proteins expressed on the surface of infected cells in culture. J Virol (1980) 1.05
Cell surface antigens associated with murine leukemia virus: definition of the GL and GT antigenic systems. J Virol (1973) 1.05
Genetic control of radiation leukemia virus-induced tumorigenesis II. Influence of Srlv-1, a locus not linked to H-2. J Exp Med (1977) 1.04
Selective gene action in the specification of cell surface structure. Am J Pathol (1971) 1.04
Expression of xenotropic murine leukemia viruses as cell-surface gp70 in genetic crosses between strains DBA/2 and C57BL/6. J Exp Med (1979) 1.03
Relationships of gp70 of MuLV envelopes to gp70 components of mouse lymphocyte plasma membranes. J Exp Med (1978) 1.01
T cell surface I-J glycoprotein. Concerted action of chromosome-4 and -17 genes forms an epitope dependent on alpha-D-mannosyl residues. J Exp Med (1984) 1.01
Nucleotide sequences associated with differences in electrophoretic mobility of envelope glycoprotein gp70 and with GIX antigen phenotype of certain murine leukemia viruses. Proc Natl Acad Sci U S A (1980) 1.01
Selective up-regulation of intact, but not defective env RNAs of endogenous modified polytropic retrovirus by the Sgp3 locus of lupus-prone mice. J Immunol (2009) 0.98
Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70. Proc Natl Acad Sci U S A (1980) 0.98
Genetic control of natural immunity to ecotropic mouse leukemia viruses: immune response genes. Infect Immun (1976) 0.95
Sequence analysis of Gardner-Arnstein feline leukaemia virus envelope gene reveals common structural properties of mammalian retroviral envelope genes. EMBO J (1983) 0.95
Evidence for a new form of retroviral env transcript in leukemic and normal mouse lymphoid cells. J Virol (1983) 0.94
Endogenous retrovirus expression in stimulated murine lymphocytes. Identification of a new locus controlling mitogen induction of a defective virus. J Exp Med (1983) 0.93
Source and hormone-dependence of Gix-gp70 in mouse serum. J Exp Med (1978) 0.92
Properties of reticulum cell sarcomas in SJL/J mice. V. Nature of reticulum cell sarcoma surface antigen which induces proliferation of normal SJL/J T cells. J Exp Med (1977) 0.92
Autoimmune and lymphoproliferative disease in (B6-GIX+ X 129)F1 mice: relation to naturally occurring antibodies against murine leukemia virus-related cell surface antigens. Proc Natl Acad Sci U S A (1979) 0.92
Truncated gag products encoded by Gv-1-responsive endogenous retrovirus loci. J Virol (1989) 0.92
Leukemia in AKR mice. I. Effects of leukemic cells on antibody-forming potential of syngeneic and allogeneic normal cells. J Exp Med (1976) 0.91
Genetic control of natural immunity to ecotropic mouse leukemia viruses: production of endogenous immunogen. Infect Immun (1976) 0.89
Inhibition of AKR leukemogenesis by SMX-1, a dualtropic murine leukemia virus. Proc Natl Acad Sci U S A (1980) 0.89
Association of endogenous retroviruses with radiation-induced leukemias of BALB/c mice. J Virol (1980) 0.88
Genetic analysis of Gv1, a gene controlling transcription of endogenous murine polytropic proviruses. J Virol (1999) 0.88
Dissection of genetic mechanisms governing the expression of serum retroviral gp70 implicated in murine lupus nephritis. J Immunol (2008) 0.88
Murine leukemia virus sequences are encoded in the murine major histocompatibility complex. Proc Natl Acad Sci U S A (1984) 0.88
TLR-mediated up-regulation of serum retroviral gp70 is controlled by the Sgp loci of lupus-prone mice. J Autoimmun (2010) 0.87
Independent segregation of the H-2 locus and the locus for responsiveness to histamine-sensitizing factor. Proc Natl Acad Sci U S A (1973) 0.86
Immune responses in vitro. VI. Genetic control of the in vivo-in vitro discrepancies in 19S antibody synthesis. J Exp Med (1972) 0.86
Association of elevated serum glycoprotein gp70 with increased gp70 immune complex formation and accelerated lupus nephritis in autoimmune male BXSB mice. Clin Exp Immunol (1984) 0.85
A cell surface antigen of the mouse related to xenotropic MuLv defined by naturally occurring antibody and monoclonal antibody. Relation to Gix G(rada1), G(aksl2) systems of MuLV-related antigens. J Exp Med (1981) 0.85
Lipopolysaccharide induces retroviral antigen expression in 129/J mouse lymphocytes: evidence for assembly of a defective viral particle. J Virol (1981) 0.85
Immunopathogenicity and oncogenicity of murine leukemia viruses. II. Infection of mice and rats with Scripps leukemia virus. Am J Pathol (1976) 0.82
The Sgp3 locus derived from the 129 strain is responsible for enhanced endogenous retroviral expression in macroH2A1-deficient mice. J Autoimmun (2010) 0.81
Bvr-1, a restriction locus of a type C RNA virus in the feline cellular genome: identification, location, and phenotypic characterization in cat X mouse somatic cell hybrids. Proc Natl Acad Sci U S A (1976) 0.79
Cross reactivity of an alloantigen present on normal cells with the tumour-specific transplantation-type antigen of the acute myeloid leukaemia (SAL) of rats. Br J Cancer (1976) 0.79
Depression of alloantigens in malignancy. Evidence for tumour susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in the microcytotoxicity assay. Br J Cancer Suppl (1973) 0.79
Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). I. Detection of group and type specific antigens by complement fixation. Br J Cancer (1974) 0.78
Recombinant origins of leukemogenic murine viruses. Parke-Davis award lecture, 1978. Am J Pathol (1978) 0.77
Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). II. Detection of cell-surface antigens by indirect membrane immunofluorescence. Br J Cancer (1974) 0.75
Membrane fluidity, capping of cell-surface antigens and immune response in mouse leukaemia cells. Br J Cancer (1978) 0.75
Host-gene control of C-type tumor virus-expression and tumorigenesis: relevance of studies in inbred mice to cancer in man and other species. Proc Natl Acad Sci U S A (1971) 0.75
Surface antigens of mammalian sarcoma virus-transformed nonproducer cells. Proc Natl Acad Sci U S A (1974) 0.75
Influence of Fv-1 alleles on cellular expression of gp70. J Exp Med (1980) 0.75
Cell surface antigen expression on chemically induced murine leukaemias. Br J Cancer (1975) 0.75
Genetic control of resistance to tumors. Am J Pathol (1978) 0.75
Cell surface antigens: invaluable landmarks reflecting the nature of cells. Cancer Immun (2012) 0.75
RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature (1970) 19.89
RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature (1970) 19.38
Isolation of naturally occurring viruses of the murine leukemia virus group in tissue culture. J Virol (1969) 9.39
Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci U S A (1969) 7.69
Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse. Proc R Soc Lond B Biol Sci (1968) 7.51
Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses. J Exp Med (1966) 6.45
The G (Gross) leukemia antigen. Cancer Res (1965) 6.07
A difference in the architecture of the surface membrane of normal and virally transformed cells. Proc Natl Acad Sci U S A (1969) 6.03
CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY. Methods Med Res (1964) 5.87
GENETIC BASIS OF SUSCEPTIBILITY TO VIRAL LEUKAEMOGENESIS. Lancet (1964) 4.83
On the natural history of the murine leukemias: presidential address. Cancer Res (1967) 4.79
SPECIFIC COMPLEMENT-FIXING VIRAL ANTIGENS IN HAMSTER AND GUINEA PIG TUMORS INDUCED BY THE SCHMIDT-RUPPIN STRAIN OF AVIAN SARCOMA. Proc Natl Acad Sci U S A (1964) 4.42
Studies on the nature and genetic control of an antigen in normal chick embryos which reacts in the COFAL test. J Gen Virol (1968) 4.11
Pathogenic properties, and "vertical" transmission of the mouse leukemia agent. Proc Soc Exp Biol Med (1951) 4.02
Synthetic DNA-RNA hybrids and RNA-RNA duplexes as templates for the polymerases of the oncogenic RNA viruses. Nature (1970) 3.98
Improved complementation in the cytotoxic test. Transplantation (1970) 3.93
Group-specific antigen expression during embryogenesis of the genome of the C-type RNA tumor virus: implications for ontogenesis and oncogenesis. Proc Natl Acad Sci U S A (1970) 3.71
Mechanism of carcinogenesis by RNA tumor viruses. I. An RNA-dependent DNA polymerase in murine sarcoma viruses. Proc Natl Acad Sci U S A (1970) 3.47
Antigens of tumors and leukemias induced by viruses. Fed Proc (1966) 3.43
The murine leukemia-sarcoma virus complex. Proc Natl Acad Sci U S A (1967) 3.24
Isolation and some characteristics of a group-specific antigen of the murine leukemia viruses. Virology (1969) 3.21
Proteins of the murine C-type RNA tumour viruses: isolation of a group-specific antigen by isoelectric focusing. J Gen Virol (1970) 2.80
G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc Natl Acad Sci U S A (1970) 2.77
Cytotoxic and neutralization tests with serum and lymph node cells of isologous mice with induced resistance against gross lymphomas. Cancer Res (1962) 2.76
Mouse leukemia virus: "spontaneous" release by mouse embryo cells after long-term in vitro cultivation. Proc Natl Acad Sci U S A (1969) 2.68
The inheritance of susceptibility to the Gross leukemia virus in mice. Genetics (1966) 2.38
Group-specific viral antigens in the milk and tissues of mice naturally infected with mammary tumor virus or Gross leukemia virus. Virology (1968) 2.26
Common properties of the oncogenic RNA viruses (oncornaviruses). Virology (1970) 2.20
The role of genetics in Gross virus leukemogenesis. Bibl Haematol (1970) 1.86
Wild-type Gross leukemia virus. II. Influence of immunogenetic factors on natural transmission and on the consequences of infection. J Natl Cancer Inst (1968) 1.79
Genetic transmission of viruses that incite mammary tumor in mice. Proc Natl Acad Sci U S A (1970) 1.71
Serologic approaches to the study of cancer in animals and in man. Cancer Res (1968) 1.65
Studies on mouse leukemia viruses. I. Isolation and characterization of a group-specific antigen. Virology (1969) 1.63
COMPARISON OF TUMOUR ANTIGENS IN AKR AND GROSS VIRUS (PASSAGE A)-INDUCED LEUKAEMIAS. Nature (1965) 1.43
A study of passive immunization against a transplanted G+ leukemia with specific antiserum. Proc Soc Exp Biol Med (1967) 1.38
Group-specific antigen of murine leukemia viruses in mice of low-leukemic strains. Int J Cancer (1970) 1.38
Mouse leukemia virus activation by chemical carcinogens. Science (1969) 1.36
EARLY AND LATE LEUKEMIAS IN RATS AFTER TRANSPLANTATION OF LEUKEMIC CELLS FROM AKR MICE. Cancer Res (1964) 1.30
Some characteristics of an isolated group antigen common to most strains of murine leukemia virus. Virology (1969) 1.26
Heritable histocompatibility changes: lysogeny in mice? Transplantation (1966) 0.95
An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1975) 23.42
Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J Exp Med (1975) 17.16
A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc Natl Acad Sci U S A (1977) 13.96
Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity. J Exp Med (1975) 13.69
A cell cycle regulator potentially involved in genesis of many tumor types. Science (1994) 13.00
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature (2001) 11.03
Tumor necrosis factor (TNF). Science (1985) 8.80
Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse. Proc R Soc Lond B Biol Sci (1968) 7.51
Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells. J Exp Med (1975) 7.20
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci U S A (1979) 6.93
Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A (1976) 6.82
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A (1998) 6.82
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A (1997) 6.67
Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses. J Exp Med (1966) 6.45
The G (Gross) leukemia antigen. Cancer Res (1965) 6.07
Control of mating preferences in mice by genes in the major histocompatibility complex. J Exp Med (1976) 5.52
A pseudogene homologous to mouse transplantation antigens: transplantation antigens are encoded by eight exons that correlate with protein domains. Cell (1981) 5.43
Regulation of cellular and humoral immune responses by T-cell subclasses. Cold Spring Harb Symp Quant Biol (1977) 5.21
Surface alloantigens of plasma cells. J Exp Med (1970) 5.19
T-cell regulation of antibody responses: demonstration of allotype-specific helper T cells and their specific removal by suppressor T cells. J Exp Med (1976) 5.11
A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med (1998) 5.06
Lymphocytes as models for the study of mammalian cellular differentiation. Immunol Rev (1977) 5.01
Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci U S A (1980) 4.66
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med (1998) 4.65
Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro. J Exp Med (1968) 4.63
Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice. Proc Natl Acad Sci U S A (1976) 4.52
Ly antigens as markers for functionally distinct subpopulations of thymus-derived lymphocytes of the mouse. Nature (1975) 4.34
Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera. Proc Natl Acad Sci U S A (1979) 4.14
Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A (1989) 4.13
Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A (1997) 4.10
Serological analysis of cell surface antigens of malignant human brain tumors. Proc Natl Acad Sci U S A (1978) 3.99
Improved complementation in the cytotoxic test. Transplantation (1970) 3.93
Current enigmas in cancer research. Harvey Lect (1973) 3.91
Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. Proc Natl Acad Sci U S A (1983) 3.83
p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells. Proc Natl Acad Sci U S A (1981) 3.72
Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture. Cancer Res (1981) 3.62
Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells. Proc Natl Acad Sci U S A (1982) 3.58
Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proc Natl Acad Sci U S A (1966) 3.56
Antigenic structure of cell surfaces. An immunoferritin study of the occurrence and topography of H-2' theta, and TL alloantigens on mouse cells. J Exp Med (1969) 3.53
Immunoglobulin and other surface antigens of cells of the immune system. J Exp Med (1971) 3.50
An approach to the mapping of antigens on the cell surface. Proc Natl Acad Sci U S A (1968) 3.46
Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med (1979) 3.43
Antigens of tumors and leukemias induced by viruses. Fed Proc (1966) 3.43
Ly-C: a third locus specifying alloantigens expressed only on thymocytes and lymphocytes. Transplantation (1971) 3.42
Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics. J Exp Med (1977) 3.42
Genetic linkage relationships of loci specifying differentiation alloantigens in the mouse. Transplantation (1972) 3.34
Biochemical evidence linking the GIX thymocyte surface antigen to the gp69/71 envelope glycoprotein of murine leukemia virus. J Exp Med (1975) 3.31
In-vitro demonstration of thymic hormone in the mouse by conversion of precursor cells into lymphocytes. Lancet (1973) 3.27
Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J Exp Med (1982) 3.27
Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antibody. Proc Natl Acad Sci U S A (1967) 3.26
Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity (1994) 3.24
Recognition among mice. Evidence from the use of a Y-maze differentially scented by congenic mice of different major histocompatibility types. J Exp Med (1979) 3.23
Isolation and some characteristics of a group-specific antigen of the murine leukemia viruses. Virology (1969) 3.21
Differentiation of T cells induced by preparations from thymus and by nonthymic agents. J Exp Med (1973) 3.12
Relation of GIX antigen of thymocytes to envelope glycoprotein of murine leukemia virus. J Exp Med (1975) 3.06
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci U S A (2000) 3.00
Independent differentiative pathways of Ly1 and Ly23 subclasses of T cells. Experimental production of mice deprived of selected T-cell subclasses. J Exp Med (1976) 2.99
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer (2001) 2.95
Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc Natl Acad Sci U S A (1986) 2.94
Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci U S A (1990) 2.91
Mouse isoantigens: separation of soluble TL (thymus-leukemia) antigen from soluble H-2 histocompatibility antigen by column chromatography. J Exp Med (1967) 2.86
Shared viral antigen of mammalian leukaemia viruses. Nature (1970) 2.84
Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity (2000) 2.81
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc Natl Acad Sci U S A (2000) 2.79
Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proc Natl Acad Sci U S A (1975) 2.77
G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc Natl Acad Sci U S A (1970) 2.77